myirislogo
04 September, 2015 00:40 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Icici Bank 266.85 0.60
State Bank O 232.60 0.87
Tata Stl 229.65 4.55
Hindalco In 77.20 3.42
Sslt 98.05 4.42
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Ipca Laboratories Limited
Ipca Laboratories Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:524494NSE:IPCALABBloomberg:IPCA@INReuters:IPCA.BO
Market Lot: 1Face Value: 2ISIN Demat: INE571A01020
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
30-JUL-15 IPCA Laboratories, a Mumbai-based drugmaker, will announce its first quarter financial results today, Jul. 30, 2015. 22-MAY-15 The Reserve Bank of India (RBI) said the foreign shareholding by Foreign Institutional Investors (FIIs) in Ipca Laboratories has gone below the revised threshold caution limit. Hence the restrictions placed on the purchase of shares of the above company are withdrawn with immediate effect. The RBI further no...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
IPCA Labs Q1 profit profit seen at Rs 360 mn: Angel Broking  -IRIS 30-Jul-15
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)30-Jun-2015(3)31-Mar-2015 (12)31-Mar-2014 (12)
Net sales 7509.8030599.1031817.60
Other Income41.30357.70214.30
Total Income7551.1030956.8032031.90
Cost of goods sold6757.9025646.4024295.90
OPBDIT793.205310.407736.00
PAT188.902561.104773.70
Gross Block---
Equity capital252.40252.40252.40
EPS (Rs.)-20.2937.83
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-29.14 - 44.3213.01 - 23.97
Debt / Equity (x)---
Operating margin (% of OI)10.517.224.2
Net margin (% of OI) 2.5 8.314.9
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
48, Kandivli Industrial Estate
Kandivli (West)
Mumbai
Maharashtra-400 067
PHONE
(022) 6647 4444
FAX
(022) 2868 6613
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer